Axogen Inc Stock Analysis

AXGN Stock  USD 6.52  0.35  5.09%   
Axogen Inc is undervalued with Real Value of 8.87 and Target Price of 14.0. The main objective of Axogen stock analysis is to determine its intrinsic value, which is an estimate of what Axogen Inc is worth, separate from its market price. There are two main types of Axogen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Axogen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Axogen's stock to identify patterns and trends that may indicate its future price movements.
The Axogen stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Axogen is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Axogen Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Axogen's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Axogen Stock Analysis Notes

About 78.0% of the company shares are held by institutions such as insurance companies. The book value of Axogen was presently reported as 2.22. The company recorded a loss per share of 0.51. Axogen Inc last dividend was issued on the 27th of January 2010. The entity had 105:100 split on the 11th of July 1994. AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 428 people. For more info on Axogen Inc please contact Karen Zaderej at 386 462 6800 or go to https://www.axogeninc.com.

Axogen Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Axogen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Axogen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Axogen Inc generated a negative expected return over the last 90 days
Axogen Inc has high historical volatility and very poor performance
The company reported the previous year's revenue of 159.01 M. Net Loss for the year was (21.72 M) with profit before overhead, payroll, taxes, and interest of 114.44 M.
Axogen Inc currently holds about 58.03 M in cash with (5.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.37.
Axogen Inc has a frail financial position based on the latest SEC disclosures
Over 78.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Long Term Trading Analysis for - Stock Traders Daily

Axogen Inc Upcoming and Recent Events

Earnings reports are used by Axogen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Axogen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Axogen Largest EPS Surprises

Earnings surprises can significantly impact Axogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-02-24
2019-12-31-0.09-0.1-0.0111 
2018-02-28
2017-12-31-0.08-0.070.0112 
2017-05-04
2017-03-31-0.1-0.11-0.0110 
View All Earnings Estimates

Axogen Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Axogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axogen Inc backward and forwards among themselves. Axogen's institutional investor refers to the entity that pools money to purchase Axogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Tocqueville Asset Management L.p.2023-12-31
769.9 K
Silvercrest Asset Management Group Llc2023-12-31
756.2 K
Dimensional Fund Advisors, Inc.2023-12-31
579.3 K
Deutsche Bank Ag2023-12-31
578.6 K
D. E. Shaw & Co Lp2023-09-30
575.4 K
Bank Of America Corp2023-12-31
521.7 K
Northern Trust Corp2023-12-31
382.3 K
Nuveen Asset Management, Llc2023-12-31
353.1 K
Charles Schwab Investment Management Inc2023-12-31
331.3 K
Arrowmark Colorado Holdings, Llc (arrowmark Partners)2023-12-31
5.2 M
Blackrock Inc2023-12-31
3.3 M
Note, although Axogen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Axogen Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 300.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Axogen's market, we take the total number of its shares issued and multiply it by Axogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Axogen Profitablity

Axogen's profitability indicators refer to fundamental financial ratios that showcase Axogen's ability to generate income relative to its revenue or operating costs. If, let's say, Axogen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Axogen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Axogen's profitability requires more research than a typical breakdown of Axogen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.11)(0.12)
Return On Capital Employed(0.13)(0.12)
Return On Assets(0.11)(0.12)
Return On Equity(0.23)(0.24)

Management Efficiency

Axogen Inc has return on total asset (ROA) of (0.0684) % which means that it has lost $0.0684 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2208) %, meaning that it created substantial loss on money invested by shareholders. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to grow to -0.12. At this time, Axogen's Debt To Assets are very stable compared to the past year. As of the 25th of April 2024, Asset Turnover is likely to grow to 0.95, though Non Currrent Assets Other are likely to grow to (83.2 M).
Last ReportedProjected for Next Year
Book Value Per Share 2.23  2.05 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 2.13  1.98 
Enterprise Value Over EBITDA(20.44)(19.41)
Price Book Value Ratio 3.06  2.91 
Enterprise Value Multiple(20.44)(19.41)
Price Fair Value 3.06  2.91 
Enterprise Value325.1 M341.4 M
The analysis of Axogen's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Axogen's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Axogen Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.016

Technical Drivers

As of the 25th of April, Axogen shows the Mean Deviation of 2.13, risk adjusted performance of (0.07), and Standard Deviation of 3.04. Axogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Axogen Inc, which can be compared to its peers. Please confirm Axogen Inc variance and potential upside to decide if Axogen Inc is priced correctly, providing market reflects its regular price of 6.52 per share. Given that Axogen has information ratio of (0.15), we suggest you to validate Axogen Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Axogen Inc Price Movement Analysis

Execute Study
The output start index for this execution was fourty-one with a total number of output elements of twenty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Axogen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Axogen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Axogen Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Axogen Predictive Daily Indicators

Axogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Axogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Axogen Corporate Filings

24th of April 2024
Other Reports
ViewVerify
4th of April 2024
Other Reports
ViewVerify
29th of March 2024
Other Reports
ViewVerify
F4
25th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
8th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
6th of March 2024
Other Reports
ViewVerify
8K
5th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
23rd of February 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Axogen Forecast Models

Axogen's time-series forecasting models are one of many Axogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Axogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Axogen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Axogen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Axogen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Axogen. By using and applying Axogen Stock analysis, traders can create a robust methodology for identifying Axogen entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.14)(0.14)
Operating Profit Margin(0.13)(0.14)
Net Loss(0.14)(0.14)
Gross Profit Margin 0.80  0.46 

Current Axogen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Axogen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Axogen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
14.0Strong Buy5Odds
Axogen Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Axogen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Axogen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Axogen Inc, talking to its executives and customers, or listening to Axogen conference calls.
Axogen Analyst Advice Details

Axogen Stock Analysis Indicators

Axogen Inc stock analysis indicators help investors evaluate how Axogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Axogen shares will generate the highest return on investment. By understating and applying Axogen stock analysis, traders can identify Axogen position entry and exit signals to maximize returns.
Begin Period Cash Flow21.5 M
Long Term Debt46.6 M
Common Stock Shares Outstanding42.9 M
Total Stockholder Equity95.7 M
Property Plant And Equipment Net104.3 M
Cash And Short Term Investments37 M
Cash37 M
Accounts Payable11.8 M
Net Debt32.3 M
50 Day M A8.45
Total Current Liabilities30.4 M
Other Operating Expenses180.5 M
Non Current Assets Total108.8 M
Stock Based Compensation14.4 M
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Axogen Inc information on this page should be used as a complementary analysis to other Axogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Axogen Stock analysis

When running Axogen's price analysis, check to measure Axogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axogen is operating at the current time. Most of Axogen's value examination focuses on studying past and present price action to predict the probability of Axogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axogen's price. Additionally, you may evaluate how the addition of Axogen to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Axogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Revenue Per Share
3.708
Quarterly Revenue Growth
0.187
Return On Assets
(0.07)
Return On Equity
(0.22)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.